In breast cancer, TIMP‐1 acts as a growth factor, promoting cell proliferation and tumorigenesis, inhibiting apoptosis, and regulating ECM degradation, which can affect drug penetration.[23]. This evidence concerns the gene TIMP1 and breast carcinoma.